Tarsus Pharmaceuticals Correlations

TARS Stock

USD 52.36 2.39 4.78%

The current 90-days correlation between Tarsus Pharmaceuticals and Travere Therapeutics is 0.18 (i.e., Average diversification). The correlation of Tarsus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tarsus Pharmaceuticals Correlation With Market

Average diversification

The correlation between Tarsus Pharmaceuticals and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tarsus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.

Moving together with Tarsus Stock

0.76	ELVN	Enliven Therapeutics	Pair Corr
0.67	GPCR	Structure Therapeutics	Pair Corr
0.71	ZURA	Zura Bio Limited	Pair Corr
0.78	IMMX	Immix Biopharma	Pair Corr
0.64	IMRX	Immuneering Corp	Pair Corr
0.71	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.64	PMVP	Pmv Pharmaceuticals	Pair Corr
0.69	PYXS	Pyxis Oncology	Pair Corr
0.73	AVTE	Aerovate Therapeutics	Pair Corr

Moving against Tarsus Stock

0.65	GILD	Gilead Sciences Sell-off Trend	Pair Corr
0.6	AZN	AstraZeneca PLC ADR	Pair Corr
0.56	SNY	Sanofi ADR	Pair Corr
0.49	OCX	OncoCyte Corp	Pair Corr
0.44	LLY	Eli Lilly	Pair Corr
0.39	GOSS	Gossamer Bio	Pair Corr
0.31	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.6	AMGN	Amgen Inc	Pair Corr
0.54	DRMAW	Dermata Therapeutics	Pair Corr

Related Correlations Analysis

	LIAN	ALDX	TVTX	ETON	CNTB	ABOS	NUVB	ELDN	OPT	CNTA
LIAN		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LIAN
ALDX	0.0		0.54	0.26	-0.75	-0.81	-0.75	-0.38	0.38	0.06	ALDX
TVTX	0.0	0.54		0.73	-0.39	-0.51	-0.44	0.27	0.72	0.17	TVTX
ETON	0.0	0.26	0.73		-0.27	-0.43	-0.4	0.32	0.61	0.21	ETON
CNTB	0.0	-0.75	-0.39	-0.27		0.8	0.8	0.47	-0.24	0.08	CNTB
ABOS	0.0	-0.81	-0.51	-0.43	0.8		0.92	0.53	-0.4	0.18	ABOS
NUVB	0.0	-0.75	-0.44	-0.4	0.8	0.92		0.49	-0.38	0.19	NUVB
ELDN	0.0	-0.38	0.27	0.32	0.47	0.53	0.49		0.44	0.4	ELDN
OPT	0.0	0.38	0.72	0.61	-0.24	-0.4	-0.38	0.44		0.11	OPT
CNTA	0.0	0.06	0.17	0.21	0.08	0.18	0.19	0.4	0.11		CNTA
	LIAN	ALDX	TVTX	ETON	CNTB	ABOS	NUVB	ELDN	OPT	CNTA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NUVB	+ 0.92	ABOS
ABOS	+ 0.8	CNTB
NUVB	+ 0.8	CNTB
ETON	+ 0.73	TVTX
OPT	+ 0.72	TVTX
OPT	+ 0.61	ETON

High negative correlations

ABOS	- 0.81	ALDX
NUVB	- 0.75	ALDX
CNTB	- 0.75	ALDX
ABOS	- 0.51	TVTX
NUVB	- 0.44	TVTX
ABOS	- 0.43	ETON

Risk-Adjusted Indicators

There is a big difference between Tarsus Stock performing well and Tarsus Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tarsus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIAN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ALDX	3.07	0.47	0.11	(0.47)	4.32	(3.48)	6.73	(4.97)	27.27
TVTX	2.95	0.42	0.12	0.19	2.98	(3.72)	6.29	(4.94)	20.04
ETON	3.59	0.36	0.08	0.34	4.26	(3.92)	7.74	(6.17)	25.22
CNTB	3.50	(0.33)	0.00	(0.37)	0.00	0.00	7.59	(7.07)	29.84
ABOS	3.02	(0.59)	0.00	(0.49)	0.00	0.00	6.57	(7.09)	19.77
NUVB	3.33	(0.34)	0.00	(0.48)	0.00	0.00	6.88	(7.38)	28.03
ELDN	2.75	(0.22)	0.00	(0.18)	0.00	0.00	4.71	(5.28)	18.63
OPT	4.37	0.13	0.02	0.13	6.72	(4.61)	8.61	(7.55)	44.59
CNTA	3.13	0.06	0.02	0.19	3.43	(3.39)	6.30	(5.83)	15.09

Tarsus Pharmaceuticals Corporate Management

Leonard JD	Chief Officer	Profile
Scott Youmans	Vice Sales	Profile
Seshadri Neervannan	Chief Officer	Profile
Adrienne Kemp	Senior Communications	Profile
Elizabeth MD	Chief Director	Profile
Aziz MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC